
ANI Pharmaceuticals, Inc. (ANIP) stock: analyst price target and their real reliability
📈 ANI Pharmaceuticals, Inc. (ANIP) stock price
🎯 ANIP price target & analyst consensus — price $73.51
⭐ The most reliable of them, either direction: Guggenheim — 69% of its targets hit on this sector (49 calls tested). It aims for $119 (+62 %), call made on August 11, 2026, maturing on August 11, 2027 (17 d ago).
All 52 calls, one by one, with our verdict on each firm.
→ See all 52 targets, analyst by analystTheir real reliability on ANIP, firm by firm: who was right, who was wrong.
→ See their reliability on ANIP🔎 Detailed analyses
✅ Historical analyst reliability on ANIP
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Roth Capital | 100% | +120.7% | 2 |
| Cantor Fitzgerald ↗ | 100% | +17.2% | 2 |
| Canaccord Genuity ↗ | 80% | +14.2% | 5 |
| HC Wainwright & Co. ↗ | 73% | +25.5% | 15 |
| Guggenheim ↗ | 57% | +6.5% | 14 |
| Oppenheimer ↗ | 50% | +42.0% | 4 |
| Raymond James ↗ | 42% | +2.0% | 12 |
| Truist Securities ↗ | 33% | +2.7% | 6 |
📊 What $1,000 invested in ANI Pharmaceuticals, Inc. would be worth › open the full page
If I'd invested $1,000 in ANI Pharmaceuticals, Inc.
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $1,457 | +46% |
| 3 years ago | $2,002 | +100% |
| 5 years ago | $2,774 | +177% |
Return by year (ANI Pharmaceuticals, Inc.)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | +2% | $1,020 (+2%) |
| 2025 | +43% | $1,457 (+46%) |
| 2024 | +0% | $1,461 (+46%) |
📰 Recent news on ANI Pharmaceuticals, Inc.
📋 All analyst calls on ANIP
matures : Aug 10, 27
matures : Aug 10, 27
matures : Jul 17, 27
matures : Jul 10, 27
matures : Jan 16, 27
matures : Dec 9, 26
matures : Nov 10, 26
matures : Oct 9, 26
See the other 44 calls, newest to oldest
matures : Sep 24, 26
matures : Sep 17, 26
matures : Sep 8, 26
matures : Aug 11, 26
matures : Apr 21, 26
matures : Oct 22, 25
matures : Sep 11, 25
Frequently asked questions
Should I buy ANI Pharmaceuticals, Inc. stock?
This isn't buy advice. For ANI Pharmaceuticals, Inc., the analyst consensus is "Buy", with an average price target of $105 (+42% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (2 calls tracked on ANI Pharmaceuticals, Inc.). We show the numbers — you decide.
Is it too late to buy ANI Pharmaceuticals, Inc.? How high can it go?
The most bullish analyst target on ANI Pharmaceuticals, Inc. is $119 (+62% above today's price); the average is $105. That's the upside they see. Check how reliable those analysts have actually been on ANI Pharmaceuticals, Inc. on our site before trusting it.
Is ANI Pharmaceuticals, Inc. still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 8 analysts have a real record on ANI Pharmaceuticals, Inc., the best hitting 100% over 2 calls. Current consensus: "Buy". Make your call on data, not noise.
What has ANI Pharmaceuticals, Inc.'s past performance been?
Historical returns and a "how much if I had invested" calculator: ANIP performance & returns.